Pfizer Stock: Ameriprise Financial’s Top Healthcare Investment in Q3

Wall St. Watchdog reveals information regarding Ameriprise Financial’s top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 426 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $12.546 billion.

  • Pfizer Inc. (NYSE:PFE): On 06/30/2011, Ameriprise Financial reported holding 62,765,135 shares with a market value of $1,292,961,805. This comprised 0.86% of the total portfolio. On 09/30/2011, Ameriprise Financial reported holding 68,234,749 shares with a market value of $1,206,390,383. This comprised 0.98% of the total portfolio. The net change in shares for this position over the two quarters is 5,469,614. About Company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • Johnson & Johnson (NYSE:JNJ): On 06/30/2011, Ameriprise Financial reported holding 10,300,499 shares with a market value of $685,189,159. This comprised 0.45% of the total portfolio. On 09/30/2011, Ameriprise Financial reported holding 11,039,066 shares with a market value of $703,078,098. This comprised 0.57% of the total portfolio. The net change in shares for this position over the two quarters is 738,567. About Company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
  • Bristol-myers Squibb Company (NYSE:BMY): On 06/30/2011, Ameriprise Financial reported holding 16,021,737 shares with a market value of $463,989,489. This comprised 0.31% of the total portfolio. On 09/30/2011, Ameriprise Financial reported holding 20,986,817 shares with a market value of $658,566,300. This comprised 0.53% of the total portfolio. The net change in shares for this position over the two quarters is 4,965,080. About Company: Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures and sells pharmaceutical and nutritional products. The Company’s products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders.
  • Merck & Co. Inc. (NYSE:MRK): On 06/30/2011, Ameriprise Financial reported holding 14,203,633 shares with a market value of $501,246,222. This comprised 0.33% of the total portfolio. On 09/30/2011, Ameriprise Financial reported holding 18,654,048 shares with a market value of $609,987,384. This comprised 0.49% of the total portfolio. The net change in shares for this position over the two quarters is 4,450,415. About Company: Merck & Co., Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of human and animal health products. Merck’s products include a treatment for elevated cholesterol, a treatment for male pattern hair loss, a preventive treatment for osteoporosis, a treatment for hypertension, and a treatment for allergic rhinitis.
  • Biogen Idec Inc. (NASDAQ:BIIB): On 06/30/2011, Ameriprise Financial reported holding 6,405,290 shares with a market value of $684,853,595. This comprised 0.45% of the total portfolio. On 09/30/2011, Ameriprise Financial reported holding 6,143,613 shares with a market value of $572,277,560. This comprised 0.46% of the total portfolio. The net change in shares for this position over the two quarters is -261,677. About Company: Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company’s products addresses diseases such as multiple sclerosis, non-Hodgkin’s lymphoma, rheumatoid arthritis, crohn’s disease, and psoriasis.
  • Allergan Inc. (NYSE:AGN): On 06/30/2011, Ameriprise Financial reported holding 5,329,173 shares with a market value of $443,653,652. This comprised 0.29% of the total portfolio. On 09/30/2011, Ameriprise Financial reported holding 6,109,375 shares with a market value of $503,290,296. This comprised 0.41% of the total portfolio. The net change in shares for this position over the two quarters is 780,202. About Company: Allergan, Inc. is a multi-specialty health care company that discovers, develops and commercializes pharmaceuticals, biologics and medical devices. The Company develops products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological and other specialty markets in countries around the world.
  • Celgene Corporation (NASDAQ:CELG): On 06/30/2011, Ameriprise Financial reported holding 6,324,191 shares with a market value of $381,475,199. This comprised 0.25% of the total portfolio. On 09/30/2011, Ameriprise Financial reported holding 6,964,825 shares with a market value of $431,192,315. This comprised 0.35% of the total portfolio. The net change in shares for this position over the two quarters is 640,634. About Company: Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.
  • Unitedhealth Group Inc. (NYSE:UNH): On 06/30/2011, Ameriprise Financial reported holding 8,465,046 shares with a market value of $436,627,088. This comprised 0.29% of the total portfolio. On 09/30/2011, Ameriprise Financial reported holding 8,879,245 shares with a market value of $409,510,770. This comprised 0.33% of the total portfolio. The net change in shares for this position over the two quarters is 414,199. About Company: UnitedHealth Group Incorporated owns and manages organized health systems in the United States and internationally. The Company provides employers products and resources to plan and administer employee benefit programs. UnitedHealth also serves the health needs of older Americans, provides specialized care services, and provides health care information and research to providers and payers.
  • Abbott Laboratories (NYSE:ABT): On 06/30/2011, Ameriprise Financial reported holding 6,843,426 shares with a market value of $360,101,069. This comprised 0.24% of the total portfolio. On 09/30/2011, Ameriprise Financial reported holding 7,566,310 shares with a market value of $386,941,089. This comprised 0.31% of the total portfolio. The net change in shares for this position over the two quarters is 722,884. About Company: Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company’s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
  • Thermo Fisher Scientific Inc. (NYSE:TMO): On 06/30/2011, Ameriprise Financial reported holding 9,021,883 shares with a market value of $580,919,041. This comprised 0.38% of the total portfolio. On 09/30/2011, Ameriprise Financial reported holding 7,612,574 shares with a market value of $385,500,743. This comprised 0.31% of the total portfolio. The net change in shares for this position over the two quarters is -1,409,309. About Company: Thermo Fisher Scientific, Inc. manufactures scientific instruments, consumables, and chemicals. The Company offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies.

(Note: Data regarding Ameriprise Financial’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet